THE USE OF EMPIRICAL ANTIBIOTICS IN THE CRITICAL CARE UNIT

R PERVAIZ; H AHMED; AHA AWAD

doi:10.54112/pjicm.v4i01.31

Authors

R PERVAIZ Department of Critical Care Medicine, Bahria International Hospital, Lahore, Pakistan
H AHMED Department of Critical Care Medicine, Bahria International Hospital, Lahore, Pakistan
AHA AWAD Department of Critical Care Medicine, Rashid Hospital, Dubai Health, UAE

DOI:

https://doi.org/10.54112/pjicm.v4i01.31

Keywords:

Antimicrobial Therapy, Empirical Treatment, Critical Care, Sepsis, Septic Shock, Diagnostic Evaluation, Microbiological Sampling

Abstract

Antimicrobial therapy plays a crucial role in managing infections in critically ill patients, yet its indiscriminate use can lead to adverse outcomes. Here, we propose a systematic approach for guiding empirical antimicrobial therapy in intensive care unit (ICU) patients with suspected infections. Diagnostic evaluation, including imaging, laboratory tests, and physical examination, is essential to assess the necessity of antimicrobial treatment. Despite advances, no gold standard biomarker for differentiating infection from inflammation necessitates thorough diagnostic assessment. Prompt microbiological sampling is crucial for accurate diagnosis and tailored treatment. Emergency initiation of antimicrobial therapy is recommended for conditions like sepsis and septic shock, emphasizing the need for timely intervention. Pathogen profiling and consideration of multidrug resistance risk factors are essential for selecting appropriate empirical therapy. Customized evaluation based on patient characteristics and regional trends is paramount for optimal antibiotic selection. Pharmacokinetic and pharmacodynamic parameters should guide dosing to ensure adequate antibacterial levels while minimizing adverse effects. Future research should focus on AI-powered decision-making systems, optimal timelines for starting or postponing therapy, and the environmental impacts of antibiotic use to enhance patient outcomes and reduce antimicrobial resistance.

References

Heming N, Azabou E, Cazaumayou X, Moine P, Annane D. Sepsis in the critically ill patient: current and emerging management strategies. Expert Review of Anti-Infective Therapy. 2021;19(5):635-47.

Niederman MS, Baron RM, Bouadma L, Calandra T, Daneman N, DeWaele J, et al. Initial antimicrobial management of sepsis. Critical care. 2021;25:1-11.

Bassetti S, Tschudin-Sutter S, Egli A, Osthoff M. Optimizing antibiotic therapies to reduce the risk of bacterial resistance. European journal of internal medicine. 2022;99:7-12.

Schmid S, Schlosser S, Gülow K, Pavel V, Müller M, Kratzer A. Interprofessional collaboration between ICU physicians, staff nurses, and hospital pharmacists optimises antimicrobial treatment and improves quality of care and economic outcome. Antibiotics. 2022;11(3):381.

Wentowski C, Ingles DP, Nielsen ND. Sepsis 2021: a review. Anaesthesia & Intensive Care Medicine. 2021;22(11):676-84.

Pak TR, Rhee C, Klompas M. Timing and spectrum of antibiotic treatment for suspected sepsis and septic shock: why so controversial? Infectious Disease Clinics of North America. 2022;36(4):719-33.

Yu D, Larsson A, Parke Å, Unge C, Henning C, Sundén-Cullberg J, et al. Single-sampling strategy vs. multi-sampling strategy for blood cultures in sepsis: a prospective non-inferiority study. Frontiers in Microbiology. 2020;11:1639.

Gavelli F, Castello LM, Avanzi GC. Management of sepsis and septic shock in the emergency department. Internal and emergency medicine. 2021;16(6):1649-61.

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Critical care medicine. 2021;49(11):e1063-e143.

Denny KJ, De Wale J, Laupland KB, Harris PN, Lipman J. When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit. Clinical Microbiology and Infection. 2020;26(1):35-40.

Kumar A. BACTERIAL ISOLATES FROM INFECTED WOUNDS AND THEIR ANTIBIOTIC SUSCEPTIBILITY PATTERN.

Stull JW, Weese JS. Nosocomial and Multidrug‐Resistant Infections. Clinical Small Animal Internal Medicine. 2020:1055-62.

Kumar NR, Balraj TA, Kempegowda SN, Prashant A. Multidrug-Resistant Sepsis: A Critical Healthcare Challenge. Antibiotics. 2024;13(1):46.

Parra-Rodriguez L, Guillamet MCV, editors. Antibiotic decision-making in the ICU. Seminars in Respiratory and Critical Care Medicine; 2022: Thieme Medical Publishers, Inc.

Chlebowski C. The Virus and the Host: Protect Yourself from Infectious Disease by Reducing Toxicity, Improving Immunity, and Minimizing Chronic Illness: Chelsea Green Publishing; 2022.

Fujii M, Karumai T, Yamamoto R, Kobayashi E, Ogawa K, Tounai M, et al. Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis. Expert Opinion on Drug Metabolism & Toxicology. 2020;16(5):415-30.

Rafailidis PI, Falagas ME. Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectives. Expert Review of Anti-infective Therapy. 2020;18(10):957-66.

Garcia E, Ly N, Diep JK, Rao GG. Moving from point‐based analysis to systems‐based modeling: integration of knowledge to address antimicrobial resistance against MDR bacteria. Clinical Pharmacology & Therapeutics. 2021;110(5):1196-206.

Pacios O, Blasco L, Bleriot I, Fernandez-Garcia L, González Bardanca M, Ambroa A, et al. Strategies to combat multidrug-resistant and persistent infectious diseases. Antibiotics. 2020;9(2):65.

Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese clinical practice guidelines for the management of sepsis and septic shock 2020 (J-SSCG 2020). Journal of intensive care. 2021;9:1-144.

Póvoa P, Moniz P, Pereira JG, Coelho L. Optimizing antimicrobial drug dosing in critically ill patients. Microorganisms. 2021;9(7):1401.

Koch BC, Muller AE, Hunfeld NG, De Winter BC, Ewoldt TM, Abdulla A, et al. Therapeutic drug monitoring of antibiotics in critically ill patients: current practice and future perspectives with a focus on clinical outcome. Therapeutic Drug Monitoring. 2022;44(1):11-8.

Rawson TM, Wilson RC, O’Hare D, Herrero P, Kambugu A, Lamorde M, et al. Optimizing antimicrobial use: challenges, advances, and opportunities. Nature Reviews Microbiology. 2021;19(12):747-58.